| Synonyms: | |
| Status: | Approved (2003) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | C10AA07 |
| UNII: | 413KH5ZJ73 |
| InChI Key | BPRHUIZQVSMCRT-VEUZHWNKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H28FN3O6S |
| Molecular Weight | 481.55 |
| AlogP | 2.4 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 140.92 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 33.0 |
| Primary Target | |
|---|---|
| hydroxymethylglutaryl-CoA reductase |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 2-4 | 17 | 1-71000 | - | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 6
Phosphodiesterase 6D
|
- | - | 1250 | - | - | |
|
Enzyme
Protease
Serine protease
Serine protease SC clan
Serine protease S9B subfamily
|
- | - | - | - | 4 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 51 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Acute Coronary Syndrome | 3 | D054058 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Hyperlipidemias | 3 | D006949 | ClinicalTrials |
| Atherosclerosis | 3 | D050197 | ClinicalTrials |
| Hip Fractures | 3 | D006620 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3 | D056648 | ClinicalTrials |
| Coronary Artery Disease | 3 | D003324 | ClinicalTrials |
| Aortic Valve Stenosis | 3 | D001024 | ClinicalTrials |
| Cardiomyopathy, Dilated | 3 | D002311 | ClinicalTrials |
| Hypertension | 3 | D006973 | ClinicalTrials |
| Renal Insufficiency | 3 | D051437 | ClinicalTrials |
| HIV Infections | 3 | D015658 | ClinicalTrials |
| Renal Insufficiency | 3 | D051437 | ClinicalTrials |
| Necrosis | 3 | D009336 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Hyperlipoproteinemia Type III | 3 | D006952 | ClinicalTrials |
| Metabolic Syndrome | 3 | D024821 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
| Stroke | 3 | D020521 | ClinicalTrials |
| Scleroderma, Systemic | 3 | D012595 | ClinicalTrials |
| HIV Infections | 3 | D015658 | ClinicalTrials |
| Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
| Obesity | 3 | D009765 | ClinicalTrials |
| Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Myocardial Infarction | 2 | D009203 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
| Diabetes Mellitus | 2 | D003920 | ClinicalTrials |
| Ischemia | 2 | D007511 | ClinicalTrials |
| Periodontitis | 2 | D010518 | ClinicalTrials |
| Pre-Eclampsia | 2 | D011225 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Hepatitis C | 2 | D006526 | ClinicalTrials |
| Venous Thromboembolism | 2 | D054556 | ClinicalTrials |
| Orthomyxoviridae Infections | 2 | D009976 | ClinicalTrials |
| Cerebral Hemorrhage | 2 | D002543 | ClinicalTrials |
| Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
| Amnesia | 2 | D000647 | ClinicalTrials |
| Sepsis | 2 | D018805 | ClinicalTrials |
| Burns | 2 | D002056 | ClinicalTrials |
| Renal Artery Obstruction | 2 | D012078 | ClinicalTrials |
| Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Tuberculosis, Pulmonary | 2 | D014397 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Depressive Disorder | 2 | D003866 | ClinicalTrials |
| Endometrial Hyperplasia | 2 | D004714 | ClinicalTrials |
| Colitis, Ulcerative | 2 | D003093 | ClinicalTrials |
| Angioedemas, Hereditary | 1 | D054179 | ClinicalTrials |
| Parkinson Disease | 1 | D010300 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Craniocerebral Trauma | 1 | D006259 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Crohn Disease | 1 | D003424 | ClinicalTrials |
| Anemia | 1 | D000740 | ClinicalTrials |
| Hypertriglyceridemia | 1 | D015228 | ClinicalTrials |
| Metabolic Diseases | 1 | D008659 | ClinicalTrials |
| Immune System Diseases | 1 | D007154 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 1 | D065626 | ClinicalTrials |
| Respiratory Syncytial Virus Infections | 1 | D018357 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 1 | D008180 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
| Asthma | 1 | D001249 | ClinicalTrials |
| Malaria | 1 | D008288 | ClinicalTrials |
| Skin Diseases | 1 | D012871 | ClinicalTrials |
| Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
| Friedreich Ataxia | 0 | D005621 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 287714-41-4 |
| ChEBI | 38545 |
| ChEMBL | CHEMBL1496 |
| DrugBank | DB01098 |
| DrugCentral | 2406 |
| EPA CompTox | DTXSID8048492 |
| FDA SRS | 413KH5ZJ73 |
| Human Metabolome Database | HMDB0015230 |
| Guide to Pharmacology | 2954 |
| PubChem | 446157 |
| SureChEMBL | SCHEMBL2520 |
| ZINC | ZINC000001535101 |